Le Lézard
Classified in: Health
Subjects: NPT, CHI

St. Jude Children's Research Hospital® kicks off THIS SHIRT SAVES LIVES T-shirt movement


NASHVILLE, Tenn., Nov. 30, 2017 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital® will kick off a nationwide campaign called "THIS SHIRT SAVES LIVES"  featuring some of the industry's biggest names and influencers in order to create a giving movement. Nashville photographers, John Shearer and Andres Martinez, have lent their talents to the campaign, shooting many of the over 80 artist images that will be featured.

St. Jude Children's Research Hospital® will kick off a nationwide campaign called,

The campaign will be supported by St. Jude Country Cares radio partners to cover more than 120 markets in December. The on-air push will coincide with a social push as artists and influencers wear and share photos in THIS SHIRT on their socials.

St. Jude has long given apparel as a thank you to "Partners In Hope," donors who give $20 per month to the hospital's lifesaving work. THIS SHIRT SAVES LIVES T-shirt will exclusively be available to those that become Partners In Hope. 

"St. Jude is an amazing organization, and whenever you see that name you trust that it's the best of all causes," said award-winning singer, songwriter and longtime St. Jude supporter Luke Bryan. "It's important for me to be a part of causes that inspire people. It's a life-changing experience to get to see St. Jude and meet the kids who are fighting for their lives."

St. Jude will officially launch the campaign with an industry-wide reception at the Country Music Association in Nashville on Monday, December 4, 2017.

Confirmed artists include: Brett Eldredge, Brothers Osborne, Cassadee Pope, Chris Janson, Chris Young, Cole Swindell, Darius Rucker, Dustin Lynch, Hunter Hayes, Jake Owen, Jon Pardi, Josh Turner, Kelsea Ballerini, Kip Moore, Lee Brice, Luke Bryan, Maren Morris, Rascal Flatts, Scotty McCreery, and Thomas Rhett.

Since 1989, Country Cares for St. Jude Kids has raised more than $750 million for the kids of St. Jude.

To join the THIS SHIRT SAVES LIVES movement, visit: www.thisshirtsaveslives.org.

About St. Jude Children's Research Hospital®
St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to drive the overall survival rate for childhood cancer to 90 percent, and we won't stop until no child dies from cancer. St. Jude freely shares the discoveries it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing or food ? because all a family should worry about is helping their child live. Join the St. Jude mission by visiting stjude.org, liking St. Jude on Facebook (facebook.com/stjude) and following us on Twitter (@stjude).

 

St. Jude Children's Research Hospital Logo

SOURCE St. Jude Children's Research Hospital


These press releases may also interest you

at 07:15
Edwards Lifesciences plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To...

at 07:15
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 07:15
NeoGenomics, Inc. , a leading oncology testing services company, today announced two promotions within its senior leadership team, effective immediately. Warren Stone has been promoted to Chief Commercial Officer and will lead NeoGenomics' clinical...

at 07:13
Calliditas Therapeutics AB ("Calliditas"), today announced additional data analyses from the 2-year Phase 3 NeflgArd trial evaluating Nefecon (TARPEYO® (budesonide) delayed-release capsules/Kinpeygo®) in patients with IgA nephropathy (IgAN), were...

at 07:13
In a significant leap towards combating health inequities and improving community health, HDR Healthcare Network is proud to implement the HealthPrevent360 program, a comprehensive healthcare solution designed to transform the landscape of preventive...

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated and metabolic diseases, today announced that the company will host a Research & Development Day from...



News published on and distributed by: